Abstract
Objectives
Age at menarche (AAM), the time of the first menstrual bleeding, is an important developmental milestone in the female life. It marks the beginning of the reproductive period. AAM is implicated in the risk of many health complications in later life. In this study, we conducted an analysis for association of single nucleotide polymorphisms (SNPs) and common haplotypes of two candidate genes, RANK (receptor activator of the NF-κB) and RANKL (receptor activator of the NF-κB ligand), with AAM in 825 unrelated Chinese women.
Methods
In total, 73 SNPs of RANKL and 23 SNPs of RANK were genotyped. The SNPs and common haplotypes were then analyzed for their association with AAM. Age and age2 were used as covariates.
Results
We found five individual SNPs (rs7239261, rs8094884, rs3826620, rs8089829, and rs9956850) of RANK significantly associated with AAM (p < 0.05). Although no significant association was identified for the RANKL gene, three polymorphisms showed nearly significant (0.05 < p < 0.08) association with AAM. Seven haplotypes of RANK were significantly associated with AAM (p < 0.05); the most significant association of the AT haplotype composed by rs1805034 and rs4524034 (p = 9.4 × 10−4) remained significant (p = 0.0235) after the Bonferroni correction for multiple testing. Three haplotypes of RANKL were significantly associated with AAM (p < 0.05). Importantly, the association of rs3826620 replicated our previous findings for Caucasian females.
Conclusions
The results of the present study suggest that the RANK and RANKL are two candidate genes for AAM in Chinese women.
Keywords: AGE AT MENARCHE, SINGLE NUCLEOTIDE POLYMORPHISMS, ASSOCIATION, RANK, RANKL, HAPLOTYPES
INTRODUCTION
Menarche is the first menstruation and normally occurs between the ages of 11 and 16 years1. Age at menarche (AAM) is a complex trait and often used in epidemiological studies as a surrogate indicator of puberty since it is difficult to accurately measure the stages of puberty using other phenotypic characters2. Age of pubertal events is important individually, socially and culturally, and has a great impact on health later in life. In particular, later AAM may increase the risk of osteoporosis3,4 and pre-eclampsia5, whereas early AAM is associated with a higher risk for endometrial6, breast7,8 and ovarian cancers9,10, psychological problems11, and obesity12,13. Therefore, the identification of the factors underlying AAM may potentially help in preventing these health complications.
Since AAM is a complex trait, it is determined by multiple environmental and genetic factors as well as by their interactions14,15. Various studies estimate a contribution of genetic factors to the variation of this trait of approximately 45–74%16,17. Previous investigations, including the recent genome-wide association studies18,19, have discovered several genomic regions, genes and single nucleotide polymorphisms (SNPs) that are the candidates for AAM.
Sex hormones play a vital role in pubertal life and possibly AAM, which is the milestone of girls’ sexual development20,21. Previous studies showed the contribution of estrogen and estrogen metabolizing genes to AAM21–24. The receptor activator of the NF-κB (RANK), located at chromosome 18, and its cognate ligand, receptor activator of the NF-κB ligand (RANKL), located at chromosome 13, together with diverse cytokines and hormones, have a great impact on various cellular processes, including bone remodeling and mammary gland development25,26. RANKL and RANK are widely expressed in osteoclasts, dendritic cells, fibroblasts, B and T lymphocytes27–29. They regulate T cell/dendritic cell communication, dendritic cell survival and activity, and lymph node formation30. RANK/RANKL system activation, combined with various cytokines and chemokines, stimulates the inflammatory state of immune response31. Furthermore, the product of the RANK and RANKL gene expression was found in mammary gland cells and was implicated in their development during lactation30. During menarche, the development of the mammary gland is followed by sexual maturation. All the above data suggest that RANK and RANKL may potentially contribute to AAM in various ways. Recently, we identified several RANK and RANKL polymorphisms and their interactions, which were associated with AAM in Caucasian females32. However, no such association studies have been conducted on the other ethnicities, including Chinese. In the present study, we attempted to replicate the above-mentioned findings about the association of RANK and RANKL with AAM in Caucasians in a large cohort of unrelated Chinese females.
METHODS
Study subjects
The study was approved by the local institutional review boards or the office of research administration of all participating institutions, Hunan Normal University and Xi’an Jiao-tong University. After signing an informed consent, all subjects were assisted in completing a structured questionnaire that included questions about anthropometric variables, lifestyle factors, and medical history. The information about AAM was collected using a questionnaire. To minimize the effect of the potential non-genetic confounding factors, a comprehensive set of exclusion criteria33 was applied. Briefly, we exclude subjects with severe chronic diseases and conditions involving vital organs (heart, lung, liver, kidney, and brain) and severe endocrinological, systemic metabolic diseases (diabetes, hypo- and hyperparathyroidism, etc.), and nutritional diseases (chronic diarrhea, chronic ulcerative colitis, etc.) that might affect regular menstrual cycles. The assessment of the exclusion criteria was conducted though the nurse-administered questionnaire and/or medical records (when available). The final study sample consisted of 825 unrelated Chinese women of Han ethnicity.
AAM was defined as the age at the first menstrual bleeding less the birth date (in years rounded to the first decimal). The general characteristics of the study subjects are given in Table 1.
Table 1.
Characteristics of the study participants. Data are given as mean ± standard error, unless otherwise indicated
| Characteristics | Average | Minimum | Maximum |
|---|---|---|---|
| n | 825 | – | – |
| Age (years) | 42.0 ± 0.4 | 22 | 77 |
| Age at menarche (years) | 13.9 ± 0.1 | 10 | 20 |
| Height (cm) | 158.4 ± 0.2 | 143 | 174 |
| Weight (kg) | 54.6 ± 0.3 | 35 | 91 |
Genotyping
Genomic DNA was isolated from leukocytes of peripheral blood using a commercially supplied kit (Gentra Systems, Inc., Minneapolis, MN, USA) and according to the manufacturer’s protocol. The SNPs were genotyped using the Affymetrix SNP Array 6.0 Set (Affymetrix, Santa Clara, CA, USA). In total, 23 SNPs located in or closely to RANK and 73 SNPs for RANKL were genotyped.
Statistical analyses
The χ2 test was applied to check the Hardy–Weinberg equilibrium (HWE) of all SNPs. SNPs that did not follow HWE were excluded from the further analysis. The effects of the SNPs and haplotypes of the RANK and RANKL genes on AAM were estimated by linear regression models. In our Chinese sample, parameters such as age, age2 were tested for their association with AAM using stepwise regression34. Significant (p ≤ 0.05) terms were included as covariates to adjust the raw AAM values for subsequent analyses. The residuals from a linear model after adjusting for the significant covariates were used as traits in the follow-up data analyses.
The association of the SNPs with AAM was analyzed by the univariate analysis of variance. In the univariate analysis, each marker was investigated independently. The obtained values were adjusted for multiple testing by applying the Bonferroni correction. The LD patterns of the RANK and RANKL genes were analyzed using the Haploview program35 (www.broad.mit.edu/mpg/haploview/). Haplotype blocks were initially determined using the procedure implemented in Haploview and then analyzed for their association with the traits under study. These analyses were conducted using the PLINK software36 available at http://pngu.mgh.harvard.edu/~purcell/plink/.
RESULTS
Study participants’ characteristics
The total sample used in the study consisted of 825 Chinese women. The AAM (mean ± standard error) of the participants was 13.9 ± 0.1 years. The basic characteristics of the participating females, including age, weight, height and AAM are summarized in Table 1.
SNP association analyses
Age and age2 were included as covariates to adjust the raw AAM values for the subsequent analyses. All studied polymorphisms indicated no deviation from the HWE (Table S1 to be found online at http://www.informahealthcare.com/doi/10.3109/13697137.2011.587556). Five RANK polymorphisms showed significant association with AAM: rs7239261 (p = 0.006), rs8094884 (p = 0.009), rs3826620 (p = 0.018), rs8089829 (p = 0.034), and rs9956850 (p = 0.046) (Table 2). The result for one of these SNPs, rs3826620, replicated our previous findings for its association with AAM in independent, healthy, Caucasian females of European descent (p = 0.022)32. The effects of the RANK polymorphisms on AAM are modest (Table 2). For example, homozygotes at the minor allele of rs7239261 have about 0.5 year later menarche (14.5 ± 0.31 years) than the average for the sample (13.9 ± 0.1 years). The contributions of rs7239261, rs8094884, rs3826620, rs8089829, and rs9956850 to the variation of AAM in Chinese were 0.5%, 0.7%, 0.2%, 0.3% and 0.1%, respectively. Interestingly, homozygotes at the minor allele of all five polymorphisms have later AAM than homozygotes at the major allele. However, no individual SNP association remained significant after the correction for multiple testing. Although the analyses did not reveal any association between the individual SNPs of the RANKL gene and AAM, three SNPs showed nearly significant association: rs7334307 (p = 0.069), rs17063218 (p = 0.070), rs7983721 (p = 0.078).
Table 2.
Significant associations for the single nucleotide polymorphisms (SNPs) of the RANK gene with age at menarche (mean ± standard error) in Chinese women. 11, 12, 22 denote homozygote at the minor allele, heterozygote and homozygote at the major allele, respectively; numbers in brackets indicate percentage of the studied sample
| SNP identity | 11 | 12 | 22 | p | p-Bonf. |
|---|---|---|---|---|---|
| rs9956850 | 14.2 ± 0.5 (1.4) | 13.8 ± 0.1 (22.7) | 14.0 ± 0.1 (75.9) | 0.046 | 1.000 |
| rs7239261 | 14.5 ± 0.3 (5.1) | 14.0 ± 0.1 (37.2) | 13.8 ± 0.1 (57.7) | 0.006 | 0.145 |
| rs3826620 | 14.1 ± 0.2 (16.5) | 14.0 ± 0.1 (48.7) | 13.8 ± 0.1 (34.8) | 0.018 | 0.436 |
| rs8094884 | 15.0 ± 0.8 (0.5) | 14.2 ± 0.1 (19.5) | 13.9 ± 0.1 (80.0) | 0.009 | 0.216 |
| rs8089829 | 14.2 ± 0.3 (4.9) | 14.0 ± 0.1 (41.9) | 13.8 ± 0.1 (53.2) | 0.034 | 0.815 |
p, unadjusted p value; p-Bonf., p value after Bonferroni correction for multiple testing
Seven haplotypes of the RANK gene were found to be significantly associated with AAM (Table 3). The association of the AT haplotype of polymorphisms rs1805034 and rs4524034 (p = 9.43 × 10−4) remained significant even after the Bonferroni correction (p = 0.024). Three haplotype blocks of RANKL were associated with AAM (Table 3). Similar to the SNPs, the effect of the haplotypes on AAM is modest. The average contribution of each haplotype of the RANK and RANKL genes to the variation of AAM in Chinese females is approximately 0.8% and 0.56%, respectively. The five haplotypes (H1, H2, H3, H5, and H6) of the RANK gene and one haplotype (h2) of the RANKL gene confer later AAM; the rest of them (H4 and H7 in RANK gene; h1 and h3 in RANKL gene) confer earlier AAM (Table 3).
Table 3.
Common haplotypes of the RANK and RANKL genes showing significant association with age at menopause in Chinese women
| Gene | Haplotype identity |
Haplotype block | Haplotype | Frequency | β | R2 | p | p-Bonf. |
|---|---|---|---|---|---|---|---|---|
| RANK | H1 | rs1805034|rs4524034 | AT | 0.100 | 0.479 | 0.014 | 9.43 × 10−4 | 0.024 |
| H2 | rs7239261|rs8086340 | AG | 0.233 | 0.266 | 0.009 | 0.009 | 0.231 | |
| H3 | rs8094884|rs4524035 | AA | 0.098 | 0.372 | 0.008 | 0.011 | 0.291 | |
| H4 | rs7239261|rs8086340 | CG | 0.139 | −0.27 | 0.006 | 0.029 | 0.301 | |
| H5 | rs12455775|rs3826620 | AT | 0.405 | 0.204 | 0.007 | 0.019 | 0.479 | |
| H6 | rs8089829|rs17069904|rs12959396 | CCA | 0.118 | 0.333 | 0.008 | 0.012 | 0.740 | |
| H7 | rs2981003|rs2981004|rs6567263| | CATCTA | 0.129 | −0.256 | 0.005 | 0.046 | 1.145 | |
| rs7233197|rs9956850|rs4941125 | ||||||||
| RANKL | h1 | rs12874142|rs7326472|rs11147871 | GTT | 0.158 | −0.237 | 0.005 | 0.043 | 0.838 |
| h2 | rs9590697|rs727243|rs12864265| | GGCCCTA | 0.604 | 0.202 | 0.007 | 0.019 | 1.924 | |
| rs7316953|rs1324005|rs9525625|rs720824 | ||||||||
| h3 | rs9525610|rs238281|rs9525613|rs430586| | TCAGTTTCC | 0.151 | −0.238 | 0.005 | 0.049 | 2.240 | |
| rs417768|rs912100|rs17063218| | ||||||||
| rs17522044|rs238270 |
p, unadjusted p value; p-Bonf., p value after Bonferroni correction for multiple testing
DISCUSSION
This study is the first to report a possible association of the RANK and RANKL genes with AAM in Chinese women of Han ethnicity. The high-affinity interaction exists between the RANK and RANKL genes, which are functionally linked, so that they are frequently considered together as to their effect on various traits32. There are several polymorphisms and haplotypes of RANK or RANKL associated with AAM in Chinese and Caucasian female subjects. This study suggests that RANK and RANKL genes are possible contributors to AAM. However, only one SNP, rs3826620, appeared to be significantly associated with AAM in both ethnicities. It may be explained by the genetic variance between different ethnic groups. Previously, we hypothesized that different prevalence of some complex traits in different ethnicities may have ethnogenetic background32. Indeed, the minor allele frequencies (MAFs) of some SNPs in RANK and RANKL in the Chinese population under present study are significantly different from those reported for Caucasians32. For example, the MAF of rs3826620 is 0.406 in Chinese and 0.266 in Caucasians; the MAF of rs12959396 is 0.143 in Chinese and 0.482 in Caucasians. In addition, the effect of rs3826620 on AAM in the Chinese population, although it has the same direction, is weaker than in Caucasians. Specifically, homozygotes at the minor allele of rs3826620 have about 0.1 years later menarche (14.1 ± 0.2 years) than heterozygotes at the major allele (14.0 ± 0.1 years), and 0.3 years later menarche than homozygotes at the major allele (13.8 ± 0.1 years) in the Chinese population; while the homozygotes at the minor allele of rs3826620 have about 0.7 years later menarche (13.7 ± 0.3 years) than heterozygotes at the major allele (13.0 ± 0.1 years), and 0.8 years later menarche than homozygotes at the major allele (12.9 ± 0.1 years) in the Caucasian population32. Overall, the minor alleles of the same RANKL polymorphisms seem to confer later timing of menarche in the Chinese population, except rs9956850 heterozygotes at the major allele (Table 2). As mentioned above, later or earlier AAM may be associated with several health complications. However, there are no data that would help to define how exactly late or early AAM will contribute to these complications. Therefore, although there is only less than 1 year’s difference between the rs3826620 genotypes, it may potentially be important for female health in later life.
The H1 haplotype of the RANK gene, composed by polymorphisms rs1805034 and rs4524034, showed a strong association with AAM. However, no association was determined for each polymorphism separately. This can be explained by the individual weak effect. The rs1805034 polymorphism is a missense variant (Ala192Val) located in exon 6. However, the potential mechanisms for the association between the H1 haplotype and AAM are yet to be elucidated.
The tumor necrosis factor (TNF) receptor superfamily, member 11α (TNFRSF11A), also known as receptor activator of nuclear factor-κB (RANK), and its cognate ligand (TNFSFII or RANKL) have been recognized as key players in many cellular and physiological processes, including bone metabolism14,37,38, lymph node organogenesis39, mammary gland development during pregnancy26, immune response28 and vascular calcification40.
At the molecular level, RANK interacts with RANKL, together with signaling molecules of the TNF receptor-associated factor (TRAF) family, to activate transcription factor NF-κB41. The transcription factor NF-κB signaling pathway plays a role in various processes of cell development and death42. Several studies have illustrated that this pathway affects some age-dependent traits, and is also involved in cell senescence43,44. The activation of NF-κB correlates with age-dependent responses in different animal models45. The role of the NF-κB signaling pathway in cell senescence was supported by results from the integrated microarray study of nine tissue types46. All these data suggest that the RANK and RANKL genes may contribute to the timing of menarche and puberty by stimulating the age-dependent mechanisms through the activation of the transcription factor NF-κB signaling pathway. Along with our previous results on Caucasians32, this study may further support that the NF-κB signaling pathway is a possible contributor to the timing of menarche in various ethnicities. However, the detailed mechanism of this contribution is still unknown.
The effect of RANK and RANKL genes on AAM is probably sex hormone-dependent. There is direct evidence that estrogen, prostaglandin and parathyroid hormone control the expression of RANK and RANKL47,48. Maturation of ovaries during puberty increases estrogen production, which, in turn, may affect RANK and RANKL expression. It is also known that estrogen, while being a major contributor to pubertal development49, is important for the timing of menarche and the menstrual period23,50. Sex hormone therapy, e.g. estrogenic and/or antiandrogenic actions, interferes with the normal onset of puberty51. It was hypothesized that the widespread presence of endocrine-disrupting chemicals, which have a predominantly estrogenic effect, may contribute to the decrease of AAM51.
The premature activation of the hypothalamic–pituitary–gonadal (HPG) axis is one of the major causes of menstrual cycle disorders52 and may result in gonadotropin-dependent precocious puberty (GDPP)53. Experiments on human breast cancer cell lines indicated that activation of tumor gonadotropin-releasing hormone (GnRH) receptors attenuated RANKL expression54. Long-acting GnRH analogs are the treatment of choice in GDPP55. With the onset of puberty, the pulsatility of output of the gonadal sex steroidal is increased markedly56. These increasing changes in circulating gonadotropin secretion levels reflect increased pulsatile secretion of GnRH and stimulate follicle maturation and estrogen synthesis in the ovaries57,58. The RANK/RANKL system seems to contribute via the HPG axis and interaction with hormones not only to AAM but to sexual maturity and puberty in general. Specifically, various female sex hormones were shown to influence the RANKL/RANK involved in proliferation of the mammalian gland59. However, the exact mechanism by which the RANK and RANKL genes interact with hormones to affect AAM is still not completely understood and needs further investigation.
Similarly to many other studies involving characteristics of reproductive history, the data of AAM were collected by questionnaire, which might potentially cause a recall error. According to the various studies, the accuracy of long-term recall of AAM ranges from 70% to 84%60,61. In this study, it is expected to be smaller than in our previous study on Caucasians32 and closer to the upper bound, because the average age of the subjects was about 42 years vs. 61 years.
Although several single polymorphism associations identified in this research became non-significant after the correction for multiple testing, they should not be ignored. The Bonferroni correction is conservative and tends to accept the null hypothesis in most cases, thus masking a potential association, especially when the effect of the given SNP is weak, which is common for pleiotropic genes. For example, our estimates of the effects of some other genes on AAM yielded similar figures, ranged between 0.1 and 2.0%34,62.
Together with our previous finding in Caucasians32, the results of the present study suggest that RANK and RANKL are associated with AAM in different ethnicities.
CONCLUSIONS
This is the first study on RANK and RANKL, two important genes for various complex traits, as possible candidate genes for the timing of menarche in Chinese women. This contribution incorporates direct SNP association and haplotype association. In the present study, we found several SNPs of RANK significantly associated with AAM. The association of one SNP, rs3826620, was a successful replication of the previous finding in the independent Caucasian sample32. We also found nearly significant association between the RANKL gene and AAM. In addition, several haplotypes of the RANK and RANKL genes were significantly associated with AAM. Our results suggested that the RANK and RANKL genes likely contribute to AAM in different ethnic populations, albeit with different strength. However, the currently available data on these genes are limited and do not allow for making any definite conclusions about an exact mechanism of this contribution. This warrants the necessity of further more extensive studies on other cohorts of women of various ethnicities.
Acknowledgments
Source of funding Investigators in this work were partially supported by grants from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, and P50 AR055081). The study also benefited from 211 State Key Research Fund by Hunan Normal University and the University of Hong Kong start-up fund (to V.D.).
Footnotes
Conflict of interest The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.
Supplementary material available online
Table S1 to be found online at http://www.informahealthcare.com/doi/10.3109/13697137.2011.587556.
References
- 1.Anderson CA, Duffy DL, Martin NG, Visscher PM. Estimation of variance components for age at menarche in twin families. Behav Genet. 2007;37:668–677. doi: 10.1007/s10519-007-9163-2. [DOI] [PubMed] [Google Scholar]
- 2.Cabanes A, Ascunce N, Vidal E, et al. Decline in age at menarche among Spanish women born from 1925 to 1962. BMC Public Health. 2009;9:449. doi: 10.1186/1471-2458-9-449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gerdhem P, Obrant KJ. Bone mineral density in old age: the influence of age at menarche and menopause. J Bone Miner Metab. 2004;22:372–375. doi: 10.1007/s00774-004-0497-z. [DOI] [PubMed] [Google Scholar]
- 4.Ito M, Yamada M, Hayashi K, et al. Relation of early menarche to high bone mineral density. Calcif Tissue Int. 1995;57:11–14. doi: 10.1007/BF00298989. [DOI] [PubMed] [Google Scholar]
- 5.Rudra CL, Williams MA. BMI as a modifying factor in the relations between age at menarche, menstrual cycle characteristics, and risk of preeclampsia. Gynecol Endocrinol. 2005;21:200–205. doi: 10.1080/09513590500168431. [DOI] [PubMed] [Google Scholar]
- 6.Xu WH, Xiang YB, Ruan ZX, et al. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer. 2004;108:613–619. doi: 10.1002/ijc.11598. [DOI] [PubMed] [Google Scholar]
- 7.Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case–control study. Int J Cancer. 1990;46:796–800. doi: 10.1002/ijc.2910460508. [DOI] [PubMed] [Google Scholar]
- 8.Petridou E, Syrigou E, Toupadaki N, et al. Determinants of age at menarche as early life predictors of breast cancer risk. Int J Cancer. 1996;68:193–198. doi: 10.1002/(SICI)1097-0215(19961009)68:2<193::AID-IJC9>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
- 9.Chiaffarino F, Pelucchi C, Parazzini F, et al. Reproductive and hormonal factors and ovarian cancer. Ann Oncol. 2001;12:337–341. doi: 10.1023/a:1011128408146. [DOI] [PubMed] [Google Scholar]
- 10.Jordan SJ, Webb PM, Green AC. Height, age at menarche, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:2045–2048. doi: 10.1158/1055-9965.EPI-05-0085. [DOI] [PubMed] [Google Scholar]
- 11.Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Early life menstrual characteristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles. J Affect Disord. 2004;79:167–176. doi: 10.1016/S0165-0327(02)00459-7. [DOI] [PubMed] [Google Scholar]
- 12.Laitinen J, Power C, Jarvelin MR. Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity. Am J Clin Nutr. 2001;74:287–294. doi: 10.1093/ajcn/74.3.287. [DOI] [PubMed] [Google Scholar]
- 13.Wang W, Zhao LJ, Liu YZ, Recker RR, Deng HW. Genetic and environmental correlations between obesity phenotypes and age at menarche. Int J Obes (Lond) 2006;30:1595–1600. doi: 10.1038/sj.ijo.0803322. [DOI] [PubMed] [Google Scholar]
- 14.Guo Y, Zhao LJ, Shen H, Deng HW. Genetic and environmental correlations between age at menarche and bone mineral density at different skeletal sites. Calcif Tissue Int. 2005;77:356–360. doi: 10.1007/s00223-005-0181-x. [DOI] [PubMed] [Google Scholar]
- 15.Loesch DZ, Huggins R, Rogucka E, Hoang NH, Hopper JL. Genetic correlates of menarcheal age: a multivariate twin study. Ann Hum Biol. 1995;22:470–490. doi: 10.1080/03014469500004152. [DOI] [PubMed] [Google Scholar]
- 16.Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman’s reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab. 1998;83:1875–1880. doi: 10.1210/jcem.83.6.4890. [DOI] [PubMed] [Google Scholar]
- 17.van den Akker OB, Stein GS, Neale MC, Murray RM. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet Med Gemellol (Roma) 1987;36:541–548. doi: 10.1017/s0001566000006929. [DOI] [PubMed] [Google Scholar]
- 18.Sulem P, Gudbjartsson DF, Rafnar T, et al. Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet. 2009;41:734–738. doi: 10.1038/ng.383. [DOI] [PubMed] [Google Scholar]
- 19.Zhao J, Xiong DH, Guo Y, et al. Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in Caucasian females. Hum Reprod. 2007;22:1789–1794. doi: 10.1093/humrep/dem052. [DOI] [PubMed] [Google Scholar]
- 20.Flint J, Wu S, Shott S, Suarez E, De Luca F. Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children. J Pediatr Endocrinol Metab. 2009;22:1105–1112. doi: 10.1515/jpem.2009.22.12.1105. [DOI] [PubMed] [Google Scholar]
- 21.Guo Y, Xiong DH, Yang TL, et al. Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. Hum Mol Genet. 2006;15:2401–2408. doi: 10.1093/hmg/ddl155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Long JR, Xu H, Zhao LJ, et al. The oestrogen receptor α gene is linked and/or associated with age of menarche in different ethnic groups. J Med Genet. 2005;42:796–800. doi: 10.1136/jmg.2004.028381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mitchell ES, Farin FM, Stapleton PL, et al. Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause. 2008;15:105–111. doi: 10.1097/gme.0b013e31804d2406. [DOI] [PubMed] [Google Scholar]
- 24.Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem. 1984;20:231–236. doi: 10.1016/0022-4731(84)90209-7. [DOI] [PubMed] [Google Scholar]
- 25.Binder NB, Niederreiter B, Hoffmann O, et al. Estrogen-dependent and C–C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med. 2009;15:417–424. doi: 10.1038/nm.1945. [DOI] [PubMed] [Google Scholar]
- 26.Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 2000;103:41–50. doi: 10.1016/s0092-8674(00)00103-3. [DOI] [PubMed] [Google Scholar]
- 27.George S, Brenner A, Sarantopoulos J, Bukowski RM. RANK ligand: effects of inhibition. Curr Oncol Rep. 2010;12:80–86. doi: 10.1007/s11912-010-0088-1. [DOI] [PubMed] [Google Scholar]
- 28.Fouque-Aubert A, Chapurlat R. Influence of RANKL inhibition on immune system in the treatment of bone diseases. Joint Bone Spine. 2008;75:5–10. doi: 10.1016/j.jbspin.2007.05.004. [DOI] [PubMed] [Google Scholar]
- 29.Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997;390:175–179. doi: 10.1038/36593. [DOI] [PubMed] [Google Scholar]
- 30.Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795–823. doi: 10.1146/annurev.immunol.20.100301.064753. [DOI] [PubMed] [Google Scholar]
- 31.Seshasayee D, Wang H, Lee WP, et al. A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. J Biol Chem. 2004;279:30202–30209. doi: 10.1074/jbc.M403968200. [DOI] [PubMed] [Google Scholar]
- 32.Lu Y, Liu P, Recker RR, Deng HW, Dvornyk V. TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women. Menopause. 2010;17:1048–1054. doi: 10.1097/gme.0b013e3181d5d523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Deng HW, Xu FH, Liu YZ, et al. A whole-genome linkage scan suggests several genomic regions potentially containing QTLs underlying the variation of stature. Am J Med Genet. 2002;113:29–39. doi: 10.1002/ajmg.10742. [DOI] [PubMed] [Google Scholar]
- 34.Liu YZ, Guo YF, Wang L, et al. Genome-wide association analyses identify SPOCK as a key novel gene underlying age at menarche. PLoS Genet. 2009;5 doi: 10.1371/journal.pgen.1000420. e1000420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457. [DOI] [PubMed] [Google Scholar]
- 36.Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575. doi: 10.1086/519795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139–146. doi: 10.1016/j.abb.2008.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Roshandel D, Holliday K, Pye SR, et al. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res. 2010;25:1830–1838. doi: 10.1002/jbmr.78. [DOI] [PubMed] [Google Scholar]
- 39.Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315–323. doi: 10.1038/16852. [DOI] [PubMed] [Google Scholar]
- 40.Osako MK, Nakagami H, Koibuchi N, et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res. 2010;107:466–475. doi: 10.1161/CIRCRESAHA.110.216846. [DOI] [PubMed] [Google Scholar]
- 41.Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem. 1998;273:20551–20555. doi: 10.1074/jbc.273.32.20551. [DOI] [PubMed] [Google Scholar]
- 42.Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene. 2006;25:6680–6684. doi: 10.1038/sj.onc.1209954. [DOI] [PubMed] [Google Scholar]
- 43.Cai D, Frantz JD, Tawa NE, Jr, et al. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell. 2004;119:285–298. doi: 10.1016/j.cell.2004.09.027. [DOI] [PubMed] [Google Scholar]
- 44.Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J Biol Chem. 2005;280:40364–40374. doi: 10.1074/jbc.M509329200. [DOI] [PubMed] [Google Scholar]
- 45.Huber N, Sakai N, Eismann T, et al. Age-related decrease in proteasome expression contributes to defective nuclear factor-κB activation during hepatic ischemia/reperfusion. Hepatology. 2009;49:1718–1728. doi: 10.1002/hep.22840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Adler AS, Sinha S, Kawahara TL, et al. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007;21:3244–3257. doi: 10.1101/gad.1588507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Li X, Pilbeam CC, Pan L, Breyer RM, Raisz LG. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone. 2002;30:567–573. doi: 10.1016/s8756-3282(02)00683-x. [DOI] [PubMed] [Google Scholar]
- 48.Seck T, Diel I, Bismar H, Ziegler R, Pfeilschifter J. Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. Eur J Endocrinol. 2001;145:199–205. doi: 10.1530/eje.0.1450199. [DOI] [PubMed] [Google Scholar]
- 49.Casazza K, Hanks LJ, Alvarez JA. Role of various cytokines and growth factors in pubertal development. Med Sport Sci. 2010;55:14–31. doi: 10.1159/000321969. [DOI] [PubMed] [Google Scholar]
- 50.Shi L, Remer T, Buyken AE, et al. Prepubertal urinary estrogen excretion and its relationship with pubertal timing. Am J Physiol Endocrinol Metab. 2010;299:E990–E997. doi: 10.1152/ajpendo.00374.2010. [DOI] [PubMed] [Google Scholar]
- 51.Mouritsen A, Aksglaede L, Sorensen K, et al. Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl. 2010;33:346–359. doi: 10.1111/j.1365-2605.2010.01051.x. [DOI] [PubMed] [Google Scholar]
- 52.Escobar ME, Pipman V, Arcari A, et al. Menstrual cycle disorders in adolescence. Arch Argent Pediatr. 2010;108:363–369. doi: 10.1590/S0325-00752010000400018. [DOI] [PubMed] [Google Scholar]
- 53.Brito VN, Latronico AC, Arnhold IJ, Mendonca BB. Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq Bras Endocrinol Metabol. 2008;52:18–31. doi: 10.1590/s0004-27302008000100005. [DOI] [PubMed] [Google Scholar]
- 54.Schubert A, Schulz H, Emons G, Grundker C. Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression. Gynecol Endocrinol. 2008;24:331–338. doi: 10.1080/09513590802095845. [DOI] [PubMed] [Google Scholar]
- 55.de Brito VN, Latronico AC, Arnhold IJ, et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Arch Dis Child. 1999;80:231–234. doi: 10.1136/adc.80.3.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Nemoto T, Yamauchi N, Shibasaki T. Novel action of pituitary urocortin 2 in the regulation of expression and secretion of gonadotropins. J Endocrinol. 2009;201:105–114. doi: 10.1677/JOE-08-0467. [DOI] [PubMed] [Google Scholar]
- 57.Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res. 1996;45:74–80. doi: 10.1159/000184763. [DOI] [PubMed] [Google Scholar]
- 58.Ebling FJ. The neuroendocrine timing of puberty. R eproduction. 2005;129:675–683. doi: 10.1530/rep.1.00367. [DOI] [PubMed] [Google Scholar]
- 59.Beleut M, Rajaram RD, Caikovski M, et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci USA. 2010;107:2989–2994. doi: 10.1073/pnas.0915148107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Casey VA, Dwyer JT, Coleman KA, et al. Accuracy of recall by middle-aged participants in a longitudinal study of their body size and indices of maturation earlier in life. Ann Hum Biol. 1991;18:155–166. doi: 10.1080/03014469100001492. [DOI] [PubMed] [Google Scholar]
- 61.Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol. 2002;155:672–679. doi: 10.1093/aje/155.7.672. [DOI] [PubMed] [Google Scholar]
- 62.Liu P, Lu Y, Recker RR, Deng HW, Dvornyk V. Association analyses suggest multiple interaction effects of the methylenetetrahydrofolate reductase polymorphisms on timing of menarche and natural menopause in white women. Menopause. 2010;17:185–190. doi: 10.1097/gme.0b013e3181aa2597. [DOI] [PMC free article] [PubMed] [Google Scholar]
